Torigen Pharmaceuticals

Farmington, United States

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.

$13.0M raised

May 2022

Series A

Biotechnology Health Care Oncology Veterinary

Top Investors

Gaingels Connecticut Innovations Everywhere Ventures Propel(X)University of Notre Dame

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Torigen Pharmaceuticals

How much funding has Torigen Pharmaceuticals raised?

Torigen Pharmaceuticals has raised $13.0M in total funding. The most recent round was Series A. The last funding was announced in May 2022.

Who are Torigen Pharmaceuticals's investors?

Torigen Pharmaceuticals's investors include Gaingels, Connecticut Innovations, Everywhere Ventures, Propel(X), University of Notre Dame.

Where is Torigen Pharmaceuticals headquartered?

Torigen Pharmaceuticals is headquartered in Farmington, United States.

What does Torigen Pharmaceuticals do?

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.

What stage is Torigen Pharmaceuticals at?

Torigen Pharmaceuticals is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 24, 2022.

MLA

"Torigen Pharmaceuticals — Funding & Investors." VCBacked, May 24, 2022, https://www.vcbacked.co/company/torigen-pharmaceuticals. Accessed July 1, 2026.

APA

VCBacked. (2022). Torigen Pharmaceuticals — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/torigen-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Torigen Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/torigen-pharmaceuticals |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 24, 2022.